Category: Life Sciences
Life Sciences market research reports by DelveInsight
-
TGF-Beta-1 Inhibitor - Pipeline Insight, 2025
DelveInsight’s, “TGF-Beta-1 Inhibitor - Pipeline Insight, 2025” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in TGF-Beta-1 Inhibitor pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the the ... Read More
-
Serotonin Reuptake Inhibitor (SRI) - Pipeline Insight, 2025
“Serotonin Reuptake Inhibitor (SRI) - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Serotonin Reuptake Inhibitor (SRI) development. The report provides detailed coverage of the pipeli ... Read More
-
Murine Double Minute 2 (MDM2) Inhibitor - Pipeline Insight, 2025
“Murine Double Minute 2 (MDM2) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Murine Double Minute 2 (MDM2) Inhibitor development. The report provides detailed coverage of ... Read More
-
Interleukin-17 (IL-17) Inhibitor - Pipeline Insight, 2025
“Interleukin-17 (IL-17) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Interleukin-17 (IL-17) Inhibitor development. The report provides detailed coverage of the pipeline l ... Read More
-
Caspase 3 (CPP32, Apopain or YAMA) Activators - Pipeline Insight, 2025
“Caspase 3 (CPP32, Apopain or YAMA) Activators - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Caspase 3 (CPP32, Apopain or YAMA) Activators development. The report provides detailed ... Read More
-
Anti-Lymphotoxin - Pipeline Insight, 2025
“Anti-Lymphotoxin - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Anti-Lymphotoxin development. The report provides detailed coverage of the pipeline landscape for this mechanism of a ... Read More
-
Anti-CD19 Antibody - Pipeline Insight, 2025
DelveInsight’s, “Anti-CD19 Antibody - Pipeline Insight, 2025” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Anti-CD19 Antibody pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the thera ... Read More
-
Alpha-1 Antagonist - Pipeline Insight, 2025
“Alpha-1 Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha-1 Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism ... Read More
-
Alpha v Beta 3 Integrin Antagonist - Pipeline Insight, 2025
“Alpha v Beta 3 Integrin Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha v Beta 3 Integrin Antagonist development. The report provides detailed coverage of the pipeli ... Read More
-
Alpha v Beta 3/5/6 Integrin Antagonist - Pipeline Insight, 2025
“Alpha v Beta 3/5/6 Integrin Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Alpha v Beta 3/5/6 Integrin Antagonist development. The report provides detailed coverage of th ... Read More
-
Akt1 Inhibitor - Pipeline Insight, 2025
“Akt1 Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Akt1 Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanism of actio ... Read More
-
Adenosine A1 Receptor Antagonist - Pipeline Insight, 2025
“Adenosine A1 Receptor Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adenosine A1 Receptor Antagonist development. The report provides detailed coverage of the pipeline l ... Read More
-
5-HT2C Agonist - Pipeline Insight, 2025
“5-HT2C Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT2C Agonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of actio ... Read More
-
5-HT4 Antagonist - Pipeline Insight, 2025
“5-HT4 Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT4 Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of a ... Read More
-
5-HT2 Agonist - Pipeline Insight, 2025
DelveInsight’s, “5-HT2 Agonist - Pipeline Insight, 2025” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in 5-HT2 Agonist pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics as ... Read More
-
11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1) Inhibitor - Pipeline Insight, 2025
“11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1) Inhibitor develo ... Read More
-
Alzheimer's Disease - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights In 2023, the 7MM reported approximately 15,840 thousand diagnosed prevalent cases of Alzheimer’s disease, reflecting a significant disease burden. This high prevalence underscores the need for innovative treatments to address the rising impact on healthcare systems and patient care. I ... Read More
-
Postpartum Depression - Market Insights, Epidemiology, and Market Forecast - 2034
Key Highlights The Postpartum Depression Treatment Market Size in the 7MM was estimated to be USD 260 million in 2023. Among EU4 and the UK, the UK accounted for the highest Postpartum Depression Market Size of ~USD 25 Million in 2023. Among the seven major countries, the Postpartum Depression diagn ... Read More
-
Heparin-induced Thrombocytopenia - Market Insight, Epidemiology, and Market Forecast - 2034
Key Highlights The heparin-induced thrombocytopenia market size in the 7MM is estimated to be around ~USD 128 million, in 2023. Heparin-induced thrombocytopenia is characterized by a rapid decrease in platelet count occurring 5–14 days after the initiation of heparin therapy. It is primarily caused ... Read More
-
KRAS Inhibitors - Market Size, Target Population, Competitive Landscape & Market Forecast - 2034
Key Highlights Among the 7MM, the United States captured the highest KRAS inhibitors market size in 2023, accounting for nearly 70% of the total KRAS Inhibitor market share. Among the approved KRAS Inhibitor therapies in the United States, KRAZATI is expected to have the edge over LUMAKRAS in revenu ... Read More
-
Gaucher’s Disease Type I - Pipeline Insight, 2025
DelveInsight’s, “Gaucher’s Disease Type I - Pipeline Insight, 2025” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Gaucher’s Disease Type I pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers ... Read More
-
Janus Kinase (JAK) Inhibitor- Pipeline Insight, 2025
DelveInsight’s, “Janus Kinase (JAK) Inhibitor- Pipeline Insight, 2025” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Janus Kinase (JAK) Inhibitor pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It als ... Read More
-
AAV Vectors in Gene Therapy- Pipeline Insight, 2025
DelveInsight’s, “AAV Vectors in Gene Therapy- Pipeline Insight, 2025” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in AAV Vectors in Gene Therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It als ... Read More
-
Huntington’s Disease - Pipeline Insight, 2025
DelveInsight’s, “Huntington’s Disease - Pipeline Insight, 2025” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Huntington’s Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the t ... Read More
-
Postpartum Depression - Pipeline Insight, 2025
DelveInsight’s, “Postpartum Depression - Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Postpartum Depression pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the ... Read More
Research Assistance
